These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 14515149)

  • 21. Peroxisome proliferator-activated receptor gamma activators inhibit MMP-1 production in human synovial fibroblasts likely by reducing the binding of the activator protein 1.
    Fahmi H; Pelletier JP; Di Battista JA; Cheung HS; Fernandes JC; Martel-Pelletier J
    Osteoarthritis Cartilage; 2002 Feb; 10(2):100-8. PubMed ID: 11869069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 15-deoxy-Delta(12,14)-prostaglandin J(2) inhibits fibrogenic response in human hepatoma cells.
    Suk FM; Chen CH; Lin SY; Cheng CJ; Yen SJ; Hung LF; Liu DZ; Liang YC
    Toxicol Lett; 2009 May; 187(1):22-7. PubMed ID: 19429239
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator-activated receptor gamma activators inhibit cardiac hypertrophy in cardiac myocytes.
    Yamamoto K; Ohki R; Lee RT; Ikeda U; Shimada K
    Circulation; 2001 Oct; 104(14):1670-5. PubMed ID: 11581147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective activation of PPARgamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator.
    Farrow B; O'Connor KL; Hashimoto K; Iwamura T; Evers BM
    Surgery; 2003 Aug; 134(2):206-12. PubMed ID: 12947319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 15-Deoxy-Delta(12,14)-prostaglandin J(2) suppresses IL-6-induced STAT3 phosphorylation via electrophilic reactivity in endothelial cells.
    Wung BS; Wu CC; Hsu MC; Hsieh CW
    Life Sci; 2006 May; 78(26):3035-42. PubMed ID: 16413037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation of hypoxia-inducible factor-1alpha through a novel electrophilic, thiol antioxidant-sensitive mechanism.
    Olmos G; Conde I; Arenas I; Del Peso L; Castellanos C; Landazuri MO; Lucio-Cazana J
    Cell Signal; 2007 Oct; 19(10):2098-105. PubMed ID: 17658243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 15-Deoxy-Delta(12,14)-prostaglandin J(2) impairs the functions of histone acetyltransferases through their insolubilization in cells.
    Hironaka A; Morisugi T; Kawakami T; Miyagi I; Tanaka Y
    Biochem Biophys Res Commun; 2009 Dec; 390(2):290-4. PubMed ID: 19799872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanomolar and micromolar effects of 15-deoxy-delta 12,14-prostaglandin J2 on amnion-derived WISH epithelial cells: differential roles of peroxisome proliferator-activated receptors gamma and delta and nuclear factor kappa B.
    Berry EB; Keelan JA; Helliwell RJ; Gilmour RS; Mitchell MD
    Mol Pharmacol; 2005 Jul; 68(1):169-78. PubMed ID: 15821150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 15d-prostaglandin J2 inhibits inflammatory hypernociception: involvement of peripheral opioid receptor.
    Napimoga MH; Souza GR; Cunha TM; Ferrari LF; Clemente-Napimoga JT; Parada CA; Verri WA; Cunha FQ; Ferreira SH
    J Pharmacol Exp Ther; 2008 Jan; 324(1):313-21. PubMed ID: 17928570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
    Shim J; Kim BH; Kim YI; Kim KY; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
    Int J Oncol; 2010 Jan; 36(1):223-31. PubMed ID: 19956851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors.
    Kim EH; Surh YJ
    Biochem Pharmacol; 2006 Nov; 72(11):1516-28. PubMed ID: 16987499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.
    Sánchez-Gómez FJ; Cernuda-Morollón E; Stamatakis K; Pérez-Sala D
    Mol Pharmacol; 2004 Nov; 66(5):1349-58. PubMed ID: 15317873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2.
    Ji JD; Kim HJ; Rho YH; Choi SJ; Lee YH; Cheon HJ; Sohn J; Song GG
    Rheumatology (Oxford); 2005 Aug; 44(8):983-8. PubMed ID: 15840591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.
    Ueki S; Kato H; Kobayashi Y; Ito W; Adachi T; Nagase H; Ohta K; Kayaba H; Chihara J
    Int Arch Allergy Immunol; 2007; 143 Suppl 1():15-22. PubMed ID: 17541271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells.
    Kondoh K; Tsuji N; Asanuma K; Kobayashi D; Watanabe N
    Exp Cell Res; 2007 Oct; 313(16):3486-96. PubMed ID: 17706193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 15-Deoxy-Delta12,14-prostaglandin J2 and thiazolidinediones transactivate epidermal growth factor and platelet-derived growth factor receptors in vascular smooth muscle cells.
    Ichiki T; Tokunou T; Fukuyama K; Iino N; Masuda S; Takeshita A
    Biochem Biophys Res Commun; 2004 Oct; 323(2):402-8. PubMed ID: 15369766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 15-Deoxy-Δ(12,14)-prostaglandin J(2) attenuates the biological activities of monocyte/macrophage cell lines.
    Liu X; Yu H; Yang L; Li C; Li L
    Eur J Cell Biol; 2012 Aug; 91(8):654-61. PubMed ID: 22560326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 15-Deoxy-Δ(12,14)-prostaglandin J(2) interferes inducible synthesis of prostaglandins E(2) and F(2α) that suppress subsequent adipogenesis program in cultured preadipocytes.
    Chowdhury AA; Rahman MS; Nishimura K; Jisaka M; Nagaya T; Ishikawa T; Shono F; Yokota K
    Prostaglandins Other Lipid Mediat; 2011 Aug; 95(1-4):53-62. PubMed ID: 21699992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 15-deoxy-Delta12,14-prostaglandin J2-induced down-regulation of endothelial nitric oxide synthase in association with HSP70 induction.
    Hwang J; Lee HI; Chang YS; Lee SJ; Kim KP; Park SI
    Biochem Biophys Res Commun; 2007 May; 357(1):206-11. PubMed ID: 17418102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of prostaglandin-J(2) on VEGF synthesis depends on the induction of heme oxygenase-1.
    Jozkowicz A; Huk I; Nigisch A; Weigel G; Weidinger F; Dulak J
    Antioxid Redox Signal; 2002 Aug; 4(4):577-85. PubMed ID: 12230869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.